Biotechnology News

August 7, 2014

VALLEY FORGE, Pa.--(BUSINESS WIRE)--The Board of Directors of AmerisourceBergen Corporation (NYSE:ABC) today declared a quarterly dividend of $0.235 per common share, payable September 2, 2014, to stockholders of record at the close of business...

August 7, 2014

MIAMI--(BUSINESS WIRE)--OPKO Health will announce top line data from the first of two identical pivotal Phase 3 clinical trials for RAYALDEE™ and its second-quarter 2014 financial results on Monday, August 11.

August 7, 2014

CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (NASDAQ:CERS) announced today that William “Obi” Greenman, president and chief executive officer, is scheduled to present a corporate update at the Wedbush 2014 Life Sciences Management Access...

August 7, 2014

BURLINGAME, Calif.--(BUSINESS WIRE)--Igenica Biotherapeutics, Inc., a company focused on the discovery and development of innovative cancer antibody-drug conjugates (ADCs), announced today the award of a $215,740 Small Business Innovation...

August 7, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, today announced that Novartis has...

August 7, 2014

PALO ALTO, Calif.--(BUSINESS WIRE)--Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) announced today that Geoff Parker, the company’s Chief Financial Officer, will provide a company overview at the following investor conferences: Wedbush Life Sciences...

August 7, 2014

COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading stem cell company focused on developing and marketing products in wound care, orthopedic and sports medicine markets announced today its financial results for...

August 7, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP) has granted Orphan Drug...

August 7, 2014

CAMBRIDGE, Mass. & ALEXANDRIA, Va.--(BUSINESS WIRE)--Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a clinical stage biopharmaceutical company developing nucleic acid therapeutics for patients with cancer and rare diseases, and The Myositis...

August 7, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a developer of innovative RNA-based therapeutics, today reported financial results for the three and six months ended June 30, 2014, and provided an update of recent...

August 7, 2014

BEDMINSTER, N.J., RESEARCH TRIANGLE PARK, N.C. & NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (Nasdaq:AERI) today announced that Vicente Anido, Jr., Ph.D., chairman and chief executive officer will present at the...

August 7, 2014

MEMPHIS, Tenn.--(BUSINESS WIRE)--GTx, Inc. (Nasdaq: GTXI) announced today that management will present a company overview on August 13, 2014, at the 2014 Wedbush Pacgrow Life Sciences Management Access Conference in New York City. The GTx...

August 7, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--BIND Therapeutics reported financial results for the second quarter ended June 30, 2014. Management to host conference call at 8:30 am ET on August 7, 2014.

August 7, 2014

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Specialty vaccine company PaxVax appoints Jonathan Klock as VP, Sales and Marketing, North America; Jeremy Gowler, VP, Global Marketing; and five U.S. National Account Directors.

August 7, 2014

EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today reported operating and financial results for the second quarter ended June 30, 2014. Quarter and Recent Highlights Increased number of unique prescribers of OTREXUP™ to over...

August 7, 2014

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Gynesonics, Inc., a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced it has named veteran medical device executive...

August 7, 2014

ROCKVILLE, Md.--(BUSINESS WIRE)--Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has submitted a Biologics License Application to the U.S. Food and Drug Administration (FDA) for Anthrax Immune Globulin Intravenous (Human) [AIGIV] as...

August 7, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc. (NASDAQ:FMI) today announced the appointment of life sciences executive Lisa Ricciardi to the newly created position of senior vice president, corporate and business development. In...

August 7, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--SAGE Therapeutics to Present at Canaccord Genuity 34th Annual Growth Conference

August 7, 2014

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (CYTR), a biopharmaceutical research and development company specializing in oncology, today announced that its oral presentation given by Sant P. Chawla, M.D., F.R.A.C.P., Director of the Sarcoma...

August 7, 2014

COPENHAGEN, Denmark--(BUSINESS WIRE)--Symphogen, a private biopharmaceutical company developing recombinant antibody mixtures, announced today that its collaborative partner, Merck KGaA, Darmstadt, Germany, through its biopharmaceutical division...

August 6, 2014

PARSIPPANY, N.J.--(BUSINESS WIRE)--The Medicines Company (NASDAQ:MDCO) today announced that the U.S. Food and Drug Administration (FDA) has approved ORBACTIV™ (oritavancin) for injection for the treatment of adults with acute bacterial skin and...

August 6, 2014

SAN FRANCISCO--(BUSINESS WIRE)--Lieff Cabraser announces that a class action lawsuit was brought against Galectin Therapeutics Inc. and the deadline to move for appointment as lead plaintiff is September 29, 2014.

August 6, 2014

AUDUBON, Pa.--(BUSINESS WIRE)--Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced that Richard Baron, Senior Vice President and Chief Financial Officer, will present at the Canaccord Genuity 34th...

August 6, 2014

ALISO VIEJO, Calif.--(BUSINESS WIRE)--An overview of upcoming events with Mauli Ola Foundation, as well as a post summary of the Breath of Life Golf Tournament.

August 6, 2014

COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--HemoGenix® announced today that results from its HALO® family of cell therapy (CT) assays, which measure stem cell quality and potency of umbilical cord blood (UCB) units prior to transplantation

August 6, 2014

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories reported second-quarter 2014 financial results

August 6, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV) today reported financial results for the quarter ended June 30, 2014. Mark Perrin, the CEO of InVivo, said, “Given the accomplishments of the first half year, I am...

August 6, 2014

BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a global biopharmaceutical company pioneering and delivering innovative therapies that transform the lives of patients with rare diseases, today reported its results for...

August 6, 2014

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”; OTCBB:ACTC), a leader in the field of regenerative medicine, announced today will host a conference call on Monday, August 11, 2014 at 5:00 p.m. EDT during which it will...

August 6, 2014

SANTA CLARA, Calif.--(BUSINESS WIRE)--XenoPort, Inc. (Nasdaq: XNPT) announced today financial results for the second quarter and six months ended June 30, 2014. Total revenues for the second quarter were $5.3 million, compared to $2.1 million for...

August 6, 2014

CARLSBAD, Calif.--(BUSINESS WIRE)--GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, will present at the Canaccord Genuity 34th Annual Growth Conference to be held at the...

August 6, 2014

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (NASDAQ: BRKR) today reported financial results for its second quarter ended June 30, 2014. Bruker’s revenues for the second quarter of 2014 grew by 0.5 percent to $457.4 million, compared to...

August 6, 2014

SAN DIEGO--(BUSINESS WIRE)--Ignyta, Inc. (Nasdaq: RXDX), an oncology precision medicine biotechnology company, announced today that it will release its second quarter 2014 financial results after the market closes on Tuesday, August 12, 2014....

August 6, 2014

OTTAWA, Ontario--(BUSINESS WIRE)--Nordion Inc. (TSX:NDN) (NYSE:NDZ), a leading provider of products and services to the global health science market, announced today the successful completion of the previously announced plan of arrangement (the “...

August 6, 2014

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--NeuroPace today announced CMS has approved New Technology Add-on Payments (NTAP) for the RNS System, the world’s only commercially available implantable closed-loop responsive neurostimulator system.

August 6, 2014

WASHINGTON--(BUSINESS WIRE)--BIO today announces a new survey tool on FDA/sponsor interactions during drug development.

August 6, 2014

PISCATAWAY, N.J.--(BUSINESS WIRE)--IEEE will launch IEEE Life Sciences Letters (LSL), a new digital, peer reviewed open-access journal, accepting submissions this Fall.

August 6, 2014

FAIR LAWN, N.J.--(BUSINESS WIRE)--Thermo Fisher Scientific: Product Name:     Fisher Chemical ChemSearch Mobile App for iOS Overview: Chemists can now use a powerful mobile tool inside and outside of the laboratory to quickly and conveniently get...

August 6, 2014

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--UCSF and Fluidigm (NASDAQ:FLDM) scientists found shallow single-cell mRNA sequencing (approximately 50K reads per cell) is sufficient for unbiased classification of cell identities.

August 6, 2014

WITTEN, Germany--(BUSINESS WIRE)--SanguiBioTech is investigating new therapeutic approaches to treating septic shock and acute respiratory distress syndrome (ARDS) by applying hemoglobin based artificial oxygen carriers.

August 6, 2014

CINCINNATI--(BUSINESS WIRE)--Meridian Bioscience, Inc. (NASDAQ: VIVO), today announced that it has entered into a technology and commercial license agreement with the University of Tennessee Research Foundation (UTRF) for the development of an...

August 6, 2014

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix International N.V. (NASDAQ: OFIX) today announced that it is delaying the release of its financial results for the fiscal quarter ended June 30, 2014. The Company requires additional time to evaluate...

August 6, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals Issues Voluntary U.S. Recall of Certain Lots of CUBICIN (daptomycin for injection) 500 mg in 10 mL single use vials
Due to Presence of Particulate Matter

August 6, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical-stage biopharmaceutical company developing a portfolio of potent new antibiotics designed to be effective against multidrug-resistant bacteria, today...

August 6, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--OvaScience to Present at the Wedbush Life Sciences Management Access Conference